How to buy PAVmed stock (PAVM)

PAVmed is a medical devices business based in the US. PAVmed shares (PAVM) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.65 – an increase of 11.34% over the previous week. PAVmed employs 107 staff and has a trailing 12-month revenue of around $3.8 million.

Our top picks for where to buy PAVmed stock

Buy PAVmed stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

PAVmed stock price (NASDAQ: PAVM)

Use our graph to track the performance of PAVM stocks over time.

PAVmed shares at a glance

• Key figures

Information last updated 2024-12-26.

Latest market close	$0.65
52-week range	$0.57 - $4.44
50-day moving average more info button	$0.96
200-day moving average more info button	$1.29
Wall St. target price	$9.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-1.14

Is it a good time to buy PAVmed stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

PAVmed price performance over time

Historical closes compared with the close of $0.6615 from 2024-12-26

1 week (2024-12-20)	13.66%
1 month (2024-11-27)	-29.63%
3 months (2024-09-27)	-43.46%
6 months (2024-06-28)	-18.83%

1 year (2023-12-28)	-83.83%
2 years (2022-12-27)	-89.41%
3 years (2021-12-28)	39.75
5 years (2019-12-27)	17.25

PAVmed financials

Revenue TTM	$3.8 million
Gross profit TTM	$-3,237,000
Return on assets TTM	-80.07%
Return on equity TTM	-1358.06%
Profit margin	0%
Book value	$-6.62
Market Capitalization more info button	$7.3 million

TTM: trailing 12 months

PAVmed share dividends

We're not expecting PAVmed to pay a dividend over the next 12 months.

Have PAVmed's shares ever split?

PAVmed's shares were split on a 1:15 basis on 6 December 2023 . So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your PAVmed shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for PAVmed shares which in turn could have impacted PAVmed's share price.

PAVmed share price volatility

Over the last 12 months, PAVmed's shares have ranged in value from as little as $0.5719 up to $4.44. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while PAVmed's is 0.693. This would suggest that PAVmed's shares are less volatile than average (for this exchange).

PAVmed overview

PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015.

Frequently asked questions

What percentage of PAVmed is owned by insiders or institutions?
Currently 10.388% of PAVmed shares are held by insiders and 14.595% by institutions. How many people work for PAVmed?
Latest data suggests 107 work at PAVmed. When does the fiscal year end for PAVmed?
PAVmed's fiscal year ends in December. Where is PAVmed based?
PAVmed's address is: 360 Madison Avenue, New York, NY, United States, 10017 What is PAVmed's ISIN number?
PAVmed's international securities identification number is: US70387R1068 What is PAVmed's CUSIP number?
PAVmed's Committee on Uniform Securities Identification Procedures number is: 70387R205